Opportunity ID: 345365

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-084
Funding Opportunity Title: Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 12, 2023
Last Updated Date: May 15, 2025
Original Closing Date for Applications: Jan 13, 2026
Current Closing Date for Applications: May 23, 2025
Archive Date: Jun 22, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
County governments
State governments
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date
Update close date per NOT-OD-25-113. May 15, 2025
Jan 12, 2023

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-084
Funding Opportunity Title: Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 12, 2023
Last Updated Date: May 15, 2025
Original Closing Date for Applications: Jan 13, 2026
Current Closing Date for Applications: May 23, 2025
Archive Date: Jun 22, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
County governments
State governments
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-084
Funding Opportunity Title: Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 12, 2023
Last Updated Date: Jan 12, 2023
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 13, 2026
Archive Date: Feb 18, 2026
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Independent school districts
Private institutions of higher education
City or township governments
Public and State controlled institutions of higher education
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Related Documents

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or before January 24, 2025 PKG00279224 Apr 13, 2023 Jan 24, 2025 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00288582 Nov 07, 2024 May 23, 2025 View

Package 1

Mandatory forms

345365 RR_SF424_5_0-5.0.pdf

345365 PHS398_CoverPageSupplement_5_0-5.0.pdf

345365 RR_OtherProjectInfo_1_4-1.4.pdf

345365 PerformanceSite_4_0-4.0.pdf

345365 RR_KeyPersonExpanded_4_0-4.0.pdf

345365 RR_Budget10_3_0-3.0.pdf

345365 PHS398_ResearchPlan_5_0-5.0.pdf

345365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

345365 RR_SubawardBudget10_30_3_0-3.0.pdf

345365 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

345365 RR_SF424_5_0-5.0.pdf

345365 PHS398_CoverPageSupplement_5_0-5.0.pdf

345365 RR_OtherProjectInfo_1_4-1.4.pdf

345365 PerformanceSite_4_0-4.0.pdf

345365 RR_KeyPersonExpanded_4_0-4.0.pdf

345365 RR_Budget10_3_0-3.0.pdf

345365 PHS398_ResearchPlan_5_0-5.0.pdf

345365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

345365 RR_SubawardBudget10_30_3_0-3.0.pdf

345365 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-10T04:07:03-05:00

Share This Post, Choose Your Platform!

About the Author: